MODERATION IN TAKING NUTRITION OF VITAMIN H (BIOTIN) KEEPS THE DOCTOR AWAY

Authors

  • Kou Hayakawa Graduate School of Health Sciences, Gunma University 3-39-15 Showa-achi, Maebashi, Gunma 371-8514, Japan. (Formerly retired) Department of Endocrinology and Metabolism, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan

DOI:

https://doi.org/10.53555/eijse.v1i2.55

Keywords:

Biotin (vitamin H), Thiol-type biotinidase/lipoamidase, Membrane components, Fucoidan, lipoic acid, avidin (biotin/lipoate-binding glycoprotein).

Abstract

English maxim says that “Feed by measure and defy the physician”.   In this review, I would like to demonstrate the truth of this proverb for biotin (vitamin H) and lipoic acid (thioctic acid).   Recently, I have found that D-biotin regulates the membrane biosynthesis in the cells.   Thus, both too extreme and too few amounts of biotin reduces the ratio of the membrane components leading to the disease.   Further, the polysaccharide fucoidan derived from the edible brown alga of Japanese Mozuku gives the adequate ratio of the membrane components via giving the measure of biotin and lipoic acid.   Thus, adequate lipoic acid-. fucoidan-, biotin-, and balanced-nutrition- intakes are expected to be the chief of all medicines combatting against such severe diseases as primary biliary cirrhosis, human liver cancer, depression, mania, cleft lip, Down syndrome, diabetes, atopic dermati- tis, amyotrophic lateral sclerosis, dementia, Alzheimer disease, and against Middle-East-respiratory- syndrome corona and human immunodeficiency viruses.   

References

. E. Kaibara, In-shoku (Eating and Drinking), in Yohjoh-kun (Instruction to Preserve the Health), vol. 3, Part 1, Fukuoka (manually written with writing brush), 1712 (in Japanese).

. F. Kögl, B. Tönnis, “Über das Bios-Problem. Darstellung von Krystallisierten Biotin aus Eigelb,” Hoppe-Seyler’s Z. Physiol. Chem., vol. 242, pp. 43–73, 1936 (in German).

. F. Lynen, “The role of biotin-dependent carboxylations in biosynthetic reactions,” Biochem. J., vol. 102, pp. 381-400, 1967.

. J. Oizumi, K. Hayakawa, “High-performance liquid chromatographic determination of four kind of biotin-containing carboxylase,” J. Chromatogr., vol. 529, pp. 55-63, 1990.

. G.M. Shull, B.L. Hutchings, W.H. Peterson, “A microbiological assay for biotin,” J. Biol. Chem., vol. 142, pp. 913-920, 1942.

. K. Hayakawa, M. Hirano, J. Oizumi, “Measurement of biotin,” Rinshou-Kensa, vol. 36, pp. 272-275, 1992 (in Japanese).

. E.E. West, P.W. Wilson, “Biotin as a growth stimulant for the root nodule bacteria,” Enzymologia, vol. 8, pp. 152-162, 1940.

. M. Koivusalo, C. Elorriaga, Y. Kaziro, S. Ochoa, “Bacterial biotinidase,” J. Biol. Chem., vol. 238, pp. 1038-1042, 1963.

. H. Wu, K. Ito, H. Shimoi, “Identification and characterization of a novel biotin biosynthesis gene in Saccharomyces cerevisiae,” Appl. Environ. Microbiol., vol. 71, pp. 6845-9855, 2005.

. U. Suzuki U, Vitamin H (Chapter 11), in The Vitamin, third edition, Nippon-Hyoron-Sha, Tokyo, p. 593, 1943 (in Japanese).

. K. Hayakawa K, N. Katsumata, M. Hirano, K. Yoshikawa, T. Ogata, T. Tanaka, T. Nagamine, “Determination of biotin (vitamin H) by the high-performance affinity chromatography with a trypsin-treated avidin-bound column,” J. Chromatogr. B, vol. 869, pp. 93-100, 2008.

. K. Hayakawa, T. Nagamine, “Fucoidan-dependent increased membrane components in HepG2 cells: effect of fucoidan is not due to gene expression,” Cancer Genom. Proteom. vol. 11, pp. 93-114, 2014.

. R.W. Thoma, W.H. Peterson, “The enzymatic degradation of soluble bound biotin,” J. Biol. Chem., vol. 210, pp. 569-579, 1954.

. L.D. Wright, C.A. Driscoll, W.P. Boger, “Biocytinase, an enzyme concerned with hydrolytic cleavage of biocytin,” Proc. Soc. Exp. Biol. Med., vol. 86, pp. 335–337, 1954.

. J. Knappe, W. Brümmer, K, “Biederbick, Reinigung und Eigenschaften der Biotinidase aus Schweinenieren und Lactobacillus casei,” Biochem. Z., vol. 338, pp. 599-613, 1963.

. K. Hayakawa, L. Guo, E.A. Terentyeva, X-K Li, H. Kimura H, M. Hirano, K. Yoshikawa, T. Nagamine, N. Katsumata, T. Ogata, T. Tanaka, “Determination of specific activities and kinetic constants of biotinidase and lipoamidase in LEW rat and Lactobacillus casei (Shirota),” J. Chromatogr. B, vol. 844, pp. 240-250, 2006.

. K. Hayakawa, J. Oizumi, “Human serum biotinidase is a thiol-type enzyme,” J. Biochem., vol. 103, pp. 773-777, 1988.

. J. Oizumi, K. Hayakawa, “Biotinidase in human breast milk,” Am. J. Clin. Nutr., vol. 48, pp. 295-297, 1988.

. J. Chauhan, K. Dakshinamurti, “Purification and characterization of human serum biotinidase,” J. Biol. Chem., vol. 261, pp. 4268-4275, 1986.

. K. Hayakawa, K. Yoshikawa, T. Watanabe, “Biotinidase: determination of enzyme activity, chemical structure such as glycochain structure and amino-acid sequence, and potential physio- logical role and possibility onto clinical application,” Vitamins (Kyoto), vol. 68, pp. 318-320, 1994 (in Japanese).

. M. Fujisaki, “Prolongation of life (Prolongatio Vitae) in the latin middle ages: Roger Bacon, Alchemy, and Roman Curia,” Shiseigaku Kenkyu (Thanatology Res.), vol. 9, pp. 224-246, 2008 (in Japanese).

. K. Abe, K. Hayakawa, K. Ihara, K. Deguchi, T. Nagamine, “Changes in the hydrophobic proteins in response to biotin administration in serum of infant patients with alopecia as assessed by the protein micro-sequencing method,” J. Microb. Biochem. Technol., vol. 7, pp. 39-46, 2015.

. K. Hayakawa, T. Nagamine, “Effect of fucoidan on the biotinidase kinetics in human hepato- cellular carcinoma,” Anticancer Res., vol. 29 pp. 1211-1218, 2009.

. K. Hayakawa, J. Oizumi, “Human serum lipoamidase,” Enzyme, vol. 40, pp. 30-36, 1988.

. L. Nilsson, B. Kågedal, “Co-purification of human serum lipoamidase and biotinidase: evidence that the two enzyme activities are due to the same enzyme protein,” Biochem. J., vol. 291, pp. 545-551, 1993.

. J.E. Halver, In Chapter 6 (The Vitamins), in Fish Feed Technology, Aquaculture development and coordination programme. Fisheries and Aquaculture Department, Food and Agriculture Organization of the United Nations, 1980. http://www.fao.org/docrep/x5738e/x5738e01.htm#TopOfPage

. K.Hayakawa, T. Nagamine, X-K Li, N. Katsumata, T. Ogata, T. Tanaka, “Affinity chromato- graphic determination of D-aspartic acid in the liver cell lines,” Trends in Chromatogr., vol. 1, pp.105-110, 2005.

. K. Hayakawa, J. Oizumi, “Isolation and characterization of human breast milk lipoamidase,” Biochim. Biophys. Acta, vol. 957, pp. 345-351, 1988.

. D.Y. Hui, K. Hayakawa, J. Oizumi, “Lipoamidase activity in normal and mutagenized pancreatic cholesterol esterase (bile salt-stimulated lipase),” Biochem. J., vol. 291, pp. 65-69, 1993.

. J. Oizumi, K. Hayakawa, “Lipoamidase (lipoyl-X hydrolase) from pig brain,” Biochem. J., vol. 266, pp. 427-434, 1990.

. K. Hayakawa, M. Hirano, J. Oizumi, M. Hosoya, “Isoelectric focusing of biotinidase and lipo- amidase with the addition of non-ionic detergent,” Anal. Chim. Acta, vol. 372, pp. 281-289, 1998.

. E.E. Snell, F.M. Strong, W.H. Peterson, “Growth factors for bacteria VI. Fractionation and properties of an accessory factor for lactic acid bacteria,” J. Bacteriol., vol. 33, pp. 1789-1799, 1937.

. L.J. Reed, “A trail of research from lipoic acid to α-keto acid dehydrogenase complexes,” J. Biol. Chem., vol. 276, pp. 38329–38336, 2001.

. J. Oizumi, K. Hayakawa, “Biotinidase in the porcine cerebrum,” Arch. Biochem. Biophys., vol. 278, pp. 381-385, 1990.

. E.B. Mckay, M.L. Molineux, R.W. Turner, “Biotin is endogenously expressed in select regions of the rat central nervous system,” J. Comp. Neurol., vol. 473, pp. 86–96, 2004.

. J. Oizumi, K. Hayakawa, “Biotinidase and lipoamidase in guinea pig livers,” Biochim. Biophys. Acta, vol. 991, pp. 410-414, 1989.

. M. Grąt, Z. Lewandowski, W. Patkowski, K.M. Wronka, K. Grąt, M. Krasnodębski, J. Ligocka, H. Zborowska, M. Krawczyk, “Relevance of male-to-female sex mismatch in liver transplanta- tion for primary biliary cirrhosis,” Ann. Transplant., vol. 20, pp. 116-123, 2015. doi: 10.12659/AOT. 892394.

. M. Cacić, E. Wilichowski, V. Mejaski-Bosnjak, K. Fumić, L. Lujić, B. Marusić Della Marina, F. Hanefeld, “Cytochrome c oxidase partial deficiency-associated Leigh disease presenting as an extrapyramidal syndrome,” J. Child. Neurol., vol. 16, pp. 616-619, 2001.

. S.J. Gould, Wonderful Life -The Burgess Shale and the Nature of the History-, Century Hutchingson, London, ISBN 0393027058, 1989.

. G.M. MacDonald, D.W. Beilman, Y.V. Kuzmin, L.A. Orlova, K.V. Kremenetski, B. Shapiro, R.K. Wayne, B. Van Valkenburgh, “Pattern of extinction of the woolly mammoth in Beringia,” Nature Commun., vol. 3, 2012. doi:10.1038/ncomms1881.

. N.M. Green, “Avidin. 1. The use of (14-C)biotin for kinetic studies and for assay,” Biochem. J., vol. 89, pp. 585–591, 1963.

. K. Hayakawa, N. Katsumata, K. Yoshikawa, M. Hirano, T. Ogata, T. Tanaka. T. Nagamine, “Determination of lipoic (thioctic) acid by high-performance affinity chromatography with a trypsin-treated avidin-bound column,” Trends in Chromatogr., vol. 3, pp. 31-42, 2007.

. S.A. Waksman, H.B. Woodruff, “The soil as a source of microorganisms antagonistic to disease- producing bacteria,” J. Bacteriol., vol. 40, pp. 581-600, 1940.

. L. Chaiet, F.J. Wolf, “The properties of streptavidin, a biotin-binding protein produced by Streptomycetes,” Arch. Biochem. Biophys., vol. 106, pp. 1–5, 1964.

. P. György, C.S. Rose, R.E. Eakin, E.E. Snell, R.J. Williams, “Egg-white injury as the result of non-absorption or inactivation of biotin,” Science, vol. 93, pp. 477-478, 1941.

. V.P. Sydenstricker, S.A. Singal, A.P. Briggs, N.M. DeVaughn, H. Isbell, “Observation on the “egg white injury” in man,” JAMA, vol. 118, pp. 1199-1200, 1942.

. J. Oizumi, K. Hayakawa, “High-performance liquid chromatographic determination of four kind of biotin-containing carboxylase,” J. Chromatogr., vol. 529, pp. 55-63, 1990.

. J. Oizumi, K. Hayakawa, “Biocytin synthetase activity in human milk as assessed by high- performance liquid chromatography,” J. Chromatogr., vol. 612, pp. 156-160, 1993.

. K. Ihara, K. Abe, K. Hayakawa, M. Makimura, K. Kojima-Ishii, T. Hara, “Biotin deficiency in a glycogen storage disease type 1b girl fed only with glycogen storage disease-related formula,” Pediatric Dermatol., vol. 28, pp. 339-341, 2011.

. K. Hayakawa, N. Katsumata, K. Abe, M. Hirano, K. Yoshikawa, T. Ogata, R. Horikawa, T. Nagamine, “Wide range of biotin (vitamin H) content in the foodstuffs and powdered milks assessed by the high-performance affinity chromatography,” Clin. Pediatr. Endocrinol., vol. 18, pp. 41-49, 2009.

. H. Cole, T.R. Reynolds, J.M. Lockyer, G.A. Buck, T. Denson T, J.E. Spence, J. Hymes, B. Wolf, “Human serum biotinidase. cDNA cloning, sequence, and characterization,” J. Biol. Chem., vol. 269, pp. 6566-6570, 1994.

. C. De Felice, K. Hayakawa, K. Nihei, S. Higuchi, T. Tanaka, T. Watanabe, I. Hibi, “Changes in cerebrospinal fluid biotinidase activity in Staphylococcus aureus meningitis,” Brain Dev. (Tokyo), vol. 16, pp. 156-158, 1994.

. N. Funeshima, M. Fujino, Y. Kitazawa, Y. Hara, Y. Hara, K. Hayakawa, T. Okuyama, H. Kimura, X-K Li, “Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase,” J. Gene Med., vol. 7, pp. 565-575, 2005.

. K. Hayakawa,T. Nagamine, “Prevention of the swell of liver tumor in Sprague-Dawley rat fed with the Kinu-Mozuku, which is an edible brown alga, grown at the seashores in Noto peninsula, Japan,” (planning to be submitted for the publication), 2015.

. K. Hayakawa, J. Oizumi, “Thermostability of human serum biotinidase activity,” Clin. Chim. Acta, vol. 178, pp. 95-100, 1988.

. V. Th. Ramaekers, T.M. Suormala, M. Brab, R. Duran, G. Heimann G, E.R. Baumgartner, “A biotinidase Km variant causing late onset bilateral optic neuropathy,” Arch. Dis. Child., vol. 67, pp. 115-119, 1992.

. S.A. Zaitone, D.M. Abo-Elmatty, A.A. Shaalan, “Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy,” Pharmacol. Biochem. Behav., vol. 100, pp. 347-360, 2012. doi: 10.1016/j.pbb.2011.09.002.

. J. Oizumi, K. Hayakawa, “Lipoamidase is a multiple hydrolase,” Biochem. J., vol. 271, pp. 45-49, 1990.

. T. Nagamine, S. Saito, S. Yamada, T. Arai, K. Takehara, T. Fukui, “Biotinidase activity in patients with liver disease,” Scand. J. Gastroenterol., vol. 28, pp. 899-906, 1993.

. K. Hayakawa, M. Hirano, K. Yoshikawa, N. Katsumata, T. Tanaka, T. Nagamine, “Determi- nation of serum biotinidase activity with biotinyl-6-aminoquinoline and its application onto the serum of gastroenterological patients,” The 50th Annual Meeting of the Vitamin Society Japan, Kyoto, Japan, May 1998 (orally presented in Japanese).

. J. Oizumi, K. Hayakawa, M. Hosoya, “Comparative study on human milk and serum bio- tinidase,” Biochimie, vol. 71, pp. 1163-1169, 1989.

. J.C. Coggeshall, J.P. Heggers, M.C. Robson, H. Baker, “Biotin status and plasma glucose in diabetics,” in: K. Dakshinamurti, H. Bhagavan (Eds.), Biotin, New York, Ann. NY Acad. Sci., vol. 447, pp. 389-392, 1985.

. A. Reddi, B. DeAngelis, O. Frank, N. Lasker, H. Baker, “Biotin supplementation improves glucose and insulin tolerances in genetically diabetic KK mice,” Life Sciences, vol. 42, pp. 1323–1330, 1988.

. M. Hirano, K. Hayakawa, N. Katsumata, T. Tanaka, “Effect of a biotin-supplemented diet on biotinidase activity in streptozotocin-induced diabetic rats,” Vitamins (Kyoto), vol. 72, pp. 49-54, 1998 (in Japanese).

. D. Koutsikos, B. Agroyannis, H. Tzanatos-Exarchou, “Biotin for diabetic peripheral neuro- pathy,” Biomed. Pharmacother., vol. 44, pp. 511–514, 1990.

. Y. Furukawa, K. Ohinata, M. Ikai, M. Maebashi, H. Zhang, S. Kimura, “Biotin-stimulated insulin secretion in biotin-deficient rats,” J. Clin. Biochem. Nutr., vol. 18, pp. 35-42, 1995.

. E.A. Terentyeva, K. Hayakawa, A. Tanae, N. Katsumata, T. Tanaka, I. Hibi, “Urinary bio- tinidase and alanine excretion in patients with insulin-dependent diabetes mellitus,” Eur. J. Clin. Chem. Clin. Biochem., vol. 35, pp. 21-24, 1997.

. O. Prakash, M.A. Eisenberg, “Active transport of biotin in Escherichia coli K-12,” J. Bacteriol., vol. 120, pp. 785-791, 1974.

. K. Hayakawa, T. Ueda, I. Kusaka, S. Fukui, “Preparation of artificial vesicles having an L-alanine uptake activity which requires NADH as energy source,” Biochem. Biophys. Res. Commun., vol. 72, pp. 1548-1553, 1976.

. T. Nagamine, K. Hayakawa, K. Nakazato, M. Iha, “Determination of the active transport of fucoidan derived from Okinawa Mozuku across the human intestinal Caco-2 cells as assessed by size-exclusion chromatography,” J. Chromatogr. B, vol. 997, pp. 187-193, 2015.

. A.J.A. Keränen, “The biotin synthesis of HeLa cells in vitro,” Cancer Res., vol. 32, pp. 119-124, 1972.

. K. Hayakawa, T. Yoshinaga, M. Hirano, K. Yoshikawa, N. Katsumata N, T. Tanaka, T. Nagamine, “Protein determination by high-performance gel-permeation chromatography: applications to human pancreatic juice, human bile and tissue homogenate,” J. Chromatogr. B, vol. 754, pp. 65-76, 2001.

. K. Hayakawa, L. Guo, E.A. Terentyeva, X-K Li, H. Kimura, M. Hirano, K. Yoshikawa, T. Yoshinaga, T. Nagamine, N. Katsumata, T. Tanaka, “Size-exclusion chromatography of bio- logical samples which contain extremely alkaline proteins,” J. Biochem. Biophys. Methods, vol. 56, pp. 153-163, 2003.

. K. Kizhatil, V. Bennett, “Lateral membrane biogenesis in human bronchial epithelial cells requires 190-kDa ankyrin-G,” J. Biol. Chem., vol. 279, pp. 16706-16714, 2004.

. J. Monod, J. Wyman, J.P. Changeux, “On the nature of allosteric transitions: A plausible model,” J. Mol. Biol., vol. 12, pp. 88-118, 1965.

. K. Hayakawa, I. Kusaka, S. Fukui, “Resistance to mercuric chloride in Pseudomonas K-62,” Agr. Biol. Chem., vol. 39, pp. 2171-2179, 1975.

. A. D'Aniello, “D-Aspartic acid: An endogenous amino acid with an important neuroendocrine role,” Brain Res. Reviews, vol. 53, pp. 215–234, 2007.

. G. Fisher, S. Lopez, K. Peterson, T. Goff, I. Philip, R. Gaviria, N. Lorenzo, M. Tsesarskaia, “Is there a correlation between age and D-aspartic acid in human knee cartilage?,” Amino Acids, vol. 32, pp. 27-30, 2007.

. J.C. Collins, E. Paietta, R. Green, A.G. Morell, R.J. Stockert, “Biotin-dependent expression of the asialoglycoprotein receptor in HepG2,” J. Biol. Chem., vol. 263, pp. 11280-11283, 1988.

. S. Woong Park, M. Klotzsche, D.J. Wilson, H.L. Boshoff, H. Eoh, H, U. Manjunatha, A. Blumenthal, K. Rhee, C.E. Barry III, C.C. Aldrich, S. Ehrt, D. Schnappinger, “Evaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene ex- pression,” PLoS Pathog., vol. 7, e1002264, 2011. doi:10.1371/journal.ppat.1002264.

. J.C. Aledo, “Glutamine breakdown in rapidly dividing cells: waste or investment?,” BioEssays, vol. 26, pp. 778-785, 2004.

. C. De Felice, K. Hayakawa, T. Tanaka, E.A. Terentyeva, “Biotinidase activity in the urine of healthy subjects,” Nephron, vol. 70, p. 115, 1995.

. P.M. Kima, X. Duana, A.S. Huanga, C.Y. Liub, G.L. Minga, H. Song, S.H. Snyder, “Aspartate racemase, generating neuronal D-aspartate, regulates adult neurogenesis,” Proc. Nat. Acad. Sci. USA, vol. 107, pp. 3175-3179, 2010.

. A. Klegeris, D.G. Walker, P.L. McGeer, “Regulation of glutamate in cultures of human mono- cytic THP-1 and astrocytoma U-373 MG cells,” J. Neuroimmunol., vol. 78, pp. 152-161, 1997.

. J.L. Levenson, “Biotin-responsive depression during hyperalimentation,” J. Parenter. Enteral. Nutr., vol. 7, pp. 181-183, 1983.

. Z. Maniecka, M. Polymenidou, “From nucleation to widespread propagation: A prion-like concept for ALS,” Virus Res., 2015. doi: 10.1016/j. virusres.2014.12.032.

. J. Oizumi, K. Hayakawa, “Enkephalin hydrolysis by human serum biotinidase,” Biochim. Biophys. Acta, vol. 1074, pp. 433-438, 1991.

. J. Oizumi, K. Hayakawa, “Release of anchored membrane enzymes by lipoamidase,” Mol. Cell. Biochem., vol. 115, pp. 11-17, 1992.

. J. Oizumi, K. Hayakawa, “Liberation of lipoate by human serum lipoamidase from bovine heart pyruvate dehydrogenase,” Biochem. Biophys. Res. Commun., vol. 162, pp. 658-663, 1989.

. J. Oizumi, K. Hayakawa, “Interaction of metals at the reaction center of lipoamidase,” Biofactors, vol. 2, pp. 127-129, 1989.

. Y. Arai, S. Yoshihara, K. Iinuma, “Brain CT studies in 26 cases of aged patients with Down syndrome,” NO TO HATTATSU, vol. 27, pp. 17-22, 1995 (in Japanese).

. P.J. Baggot, R.M. Baggot, T. Kim, J.D. Shoemaker, “Biotin-related metabolites in normal and Down syndrome amniotic fluid,” Internet J. Gynecol. Obstet., vol. 17, 2013. http://ispub.com/IJGO/17/2/2968.

. S. Sudha, S.M. Masilamani, “Characterization of cytotoxic compound from marine sediment derived actinomycetes Streptomyces avidinii starain SU4,” Asian Pac. J. Trop. Biomed., vol. 2, pp. 770-773, 2012.

. T. Watanabe, “Teratogenic effects of biotin deficiency in mice,” J. Nutr., vol. 113, pp. 574-581, 1983.

. D.M. Mock, “Marginal biotin deficiency is common in normal human pregnancy and is highly teratogenic in mice,” J. Nutr., vol. 139, pp. 154-157, 2009.

. T. Goto, T. Watanabe, A. Endo, “Sex difference in susceptibility to teratogenic effect of maternal biotin deficiency in mouse embryos,” Teratology, vol. 31, pp. 425-427, 1985.

. H. Matsuzawa, K. Hayakawa, T. Sato, K. Imahori, “Characterization and genetic analysis of a mutant of Escherichia coli K-12 with rounded morphology,” J. Bacteriol., vol. 115, pp. 436- 442, 1973.

. M.A. Hayden, I. Huang, D.E. Bussiere, G.W. Ashkey, “The biosynthesis of lipoic acid. Cloning of lip, a lipoate biosynthetic locus of Escherichia coli,” J. Biol. Chem., vol. 267, pp. 9512- 9515, 1992.

. N.G. Stoker, J.M. Pratt, B.G. Spratt, “Identification of the rodA gene product of Escherichia coli,” J. Bacteriol., vol. 155, pp. 854-859, 1983.

. J. Oizumi, K. Hayakawa, “High-performance liquid chromatographic determination of four kind of biotin-containing carboxylase,” J. Chromatogr., vol. 529, pp. 55-63, 1990.

. M. Hirano, K. Honma, T. Daimatsu, K. Hayakawa, J. Oizumi, K. Zaima, Y. Kanke, “The levels of biotin and biotinidase in bovine milk,” Anim. Sci. Technol., vol. 62, pp. 1048- 1054, 1991.

. N. Abe, H. Kawamoto, Y. Miki, T. Kimura, K. Kasagi, O. Ichikawa, K. Hiramatsu, T. Ikeda, “Effects of taking of edible fucoidan for long-time and for excess-amount to the rats,” The Proceedings of the Joined Meeting in Okinawa by Japan Society for Bioscience, Biotechno- logy, and Agrochemistry, Japan Society of Nutrition and Food Science, and Japan Food Science and Engineering Society, p 16, 31 October, 2009 (orally presented in Japanese).

. A. Synytsya, R. Bleha, A. Synytsya, R. Pohl, K. Hayashi, K. Yoshinaga, T. Nakano, T. Hayashi, “Mekabu fucoidan: structural complexity and defensive effects against avian influenza A viruses,” Carbohydr. Polym., vol. 111, pp. 633-644, 2014. doi: 10.1016/j.carbpol.2014.05.032.

. C. Bachmann, J. Schaub, J.P. Colombo, B.J. Burri, L. Sweetman L, B. Wolf, “Rett syndrome revisited: a patient with biotin dependency,” Eur. J. Pediatr., vol. 144, pp. 563-536, 1986.

. A.B. Burlina, W.G. Sherwood, F. Zacchello, “Partial biotinidase deficiency associated with Coffin-Siris syndrome,” Eur. J. Pediatr., vol. 149, pp. 628-629, 1990.

. S. Dhar, R. Banerjee, R. Malakar, “Neonatal erythroderma: diagnostic and therapeutic challenges,” Indian J. Dermatol., vol. 57, pp. 475-478, 2012. doi: 10.4103/0019-5154.103068.

. B. Maresca, L. Cigliano, M.S. Spagnuolo, F. Dal Piaz, M.M. Corsaro, N. Balato, M. Nino, A. Balato, F. Ayala, P. Abrescia, “Differences between the glycosylation patterns of haptoglobin isolated from skin scales and plasma of psoriatic patients,” PLoS One, vol. 7, e52040, 2012. doi: 10.1371/journal.pone.0052040.

Downloads

Published

2015-06-27